Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

Background In the USA, more than 50% of patients with ovarian cancer die within 5 years of diagnosis, highlighting the need for therapeutic innovations. Mesothelin (MSLN) is a candidate immunotherapy target; it is overexpressed by ovarian tumors and contributes to malignant/invasive phenotypes, maki...

Full description

Bibliographic Details
Main Authors:	Philip D Greenberg, Kristin G Anderson, Shannon K Oda, Breanna M Bates, Madison G Burnett, Magdalia Rodgers Suarez, Susan L Ruskin
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/3/e003959.full

Similar Items

803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
by: Philip D Greenberg, et al.
Published: (2023-11-01)

The Fas/Fas ligand death receptor pathway contributes to phenylalanine-induced apoptosis in cortical neurons.
by: Xiaodong Huang, et al.
Published: (2013-01-01)

D-Cyclins Repress Apoptosis in Hematopoietic Cells by Controlling Death Receptor Fas and Its Ligand FasL
by: Choi, Yoon Jong, et al.
Published: (2017)

Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death
by: Joseph H Su, et al.
Published: (2003-04-01)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
by: Fabien B Vincent, et al.
Published: (2020-12-01)

Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study
by: Rezvan Asgari, et al.
Published: (2022-01-01)

Willingness to Adopt Opt-Out Organ Donation System: Saving Life from Death
by: Sana Abbas, et al.
Published: (2023-06-01)

Species difference in the expression of Fas and Fas ligand in mature mammalian spermatozoa
by: Youwei Li, et al.
Published: (2017-12-01)

Serum Fas and Fas Ligand levels in childhood acute lymphoblastic leukemias
by: Ali Bülent Antmen, et al.
Published: (2019-12-01)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
by: Tae Woo Gu, et al.
Published: (2014-03-01)

Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens.
by: Adam J Caulfield, et al.
Published: (2014-08-01)

The In Situ Hybridization Expression of Fas and Fas Ligand (FasL) in Trophoblastic tissue of Aborted Women Compared with Normal Pregnancy.
by: Amal H. Salman, et al.
Published: (2009-07-01)

Role of Fas/Fas Ligand Pathway in a Sample of Iraqi Diabetic Foot Patients
by: Sabah Khorsheed Hussian, et al.
Published: (2019-11-01)

Role of Fas/Fas Ligand Pathway in a Sample of Iraqi Diabetic Foot Patients
by: Sabah Khorsheed Hussian, et al.
Published: (2019-11-01)

Çocukluk çağı akut lenfoblastik lösemilerde serum Fas ve Fas Ligand düzeyleri
by: Alev ARSLAN, et al.
Published: (2019-12-01)

Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.
by: Meredith S Gregory, et al.
Published: (2011-03-01)

Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.
by: Wei Liu, et al.
Published: (2015-01-01)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
by: Ikomey George M, et al.
Published: (2012-06-01)

Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.
by: Lech Chyczewski, et al.
Published: (2007-10-01)

Association of sFas and sFas ligand with progression of type 2 diabetes mellitus in Basrah province
by: Saja Majid Hamid, et al.
Published: (2018-01-01)

Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand
by: Ting-Yu Lai, et al.
Published: (2022-04-01)

Fas ligand-transfected myoblasts and islet cell transplantation.
by: Turvey, SE, et al.
Published: (2000)

Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
by: Roberta Lotti, et al.
Published: (2018-02-01)

Diagnostic significance of serum concentrations of soluble Fas ligand (sFasL) in children with autoimmune thyroid disease
by: Hanna Mikos, et al.
Published: (2017-04-01)

Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs)
by: Teresa Iwaniec, et al.
Published: (2012-01-01)

Cell Death in AMD: The Rationale for Targeting Fas
by: David N. Zacks, et al.
Published: (2022-01-01)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.
by: Simon, A, et al.
Published: (2007)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
by: Simon, A, et al.
Published: (2007)

CD95/Fas ligand mRNA is toxic to cells
by: Will Putzbach, et al.
Published: (2018-10-01)

Oxidative stress increases Fas ligand expression in endothelial cells
by: Nagai Atsushi, et al.
Published: (2006-07-01)

Potentials of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes
by: Abdel eHamad, et al.
Published: (2012-07-01)

Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy
by: Callum McKenzie, et al.
Published: (2023-06-01)

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
by: Konkankit Veerauo V, et al.
Published: (2011-11-01)

Modulation of Fas–Fas Ligand Interaction Rehabilitates Hypoxia-Induced Apoptosis of Mesenchymal Stem Cells in Ischemic Myocardium Niche
by: Onju Ham, et al.
Published: (2015-07-01)

Effect of iodide on Fas, Fas-ligand and Bcl-w mRNA expression in thyroid of NOD mice pretreated with methimazole
by: L.H.B. Boechat, et al.
Published: (2002-03-01)

Molecular studies of Fas signaling and programmed cell death
by: Chang, Howard Y. (Howard Yuan-Hao), 1972-
Published: (2010)

Identification of the Calmodulin-Binding Domains of Fas Death Receptor.
by: Bliss J Chang, et al.
Published: (2016-01-01)

Ekspresi Bcl-2, Bax, Fas dan Fas Ligand pada karsinoma duktal infiltratif payudara hubungannya dengan stadium
by: , WIDASARI, Dewiyani Indah, et al.
Published: (2010)

Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response
by: Zuzana Strizova, et al.
Published: (2021-04-01)

Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand.
by: Elizabeth H Humphreys, et al.
Published: (2010-11-01)